Cansino Biologics Inc(688185) Jinyu Bio-Technology Co.Ltd(600201) annual performance report of the audit committee of the board of directors of the company in 2021
Cansino Biologics Inc(688185) Jinyu Bio-Technology Co.Ltd(600201) company
2021 performance report of the audit committee of the board of directors
In accordance with relevant laws, regulations and normative documents such as the code for the governance of listed companies, the Listing Rules of the Shanghai Stock Exchange on the science and Innovation Board (hereinafter referred to as the “Listing Rules of the science and Innovation Board”), the rules of the stock exchange of Hong Kong Limited on the listing of securities (hereinafter referred to as the “Hong Kong Listing Rules”), and the articles of association of Cansino Biologics Inc(688185) Jinyu Bio-Technology Co.Ltd(600201) companies (hereinafter referred to as the “articles of association”) The audit committee of Cansino Biologics Inc(688185) Jinyu Bio-Technology Co.Ltd(600201) company (hereinafter referred to as “the detailed rules of the audit committee”) actively carried out various work and conscientiously performed relevant duties in accordance with the relevant provisions of the detailed rules of the audit committee of Cansino Biologics Inc(688185) Jinyu Bio-Technology Co.Ltd(600201) company (hereinafter referred to as “the company”) in 2021. The performance of the audit committee in 2021 is reported as follows:
1、 Basic information of the audit committee
On May 15, 2020, the second board of directors of the company was elected at the 2019 annual general meeting of shareholders. On the same day, the second session of the board of directors of the company held the first meeting for deliberation and elected Ms. Xin Zhu, independent director, Mr. Wei Shaokun and Mr. GUI Shuifa as members of the audit committee of the board of directors of the company. The term of office of the above members is until the expiration of the term of office of the audit committee of the board of directors, of which Ms. Xin Zhu is the chairman.
2、 Meetings of the audit committee of the board of directors
In 2021, the audit committee of the board of directors of the company actively performed the duties of the professional committee in accordance with the company law, the articles of association, the working rules of the audit committee and other relevant provisions. During the reporting period, the audit committee of the board of directors of the company held 4 meetings, and all members attended the meeting. The details are as follows:
On March 22, 2021, the audit committee of the board of directors of the company held the third meeting of the audit committee of the second board of directors. The meeting deliberated and adopted the proposal on 2020 financial final account report and financial audit report, the proposal on hiring domestic and foreign audit institutions and internal control audit institutions in 2021, and the proposal on 2020 duty performance report of the audit committee of the board of directors of the company.
On April 27, 2021, the audit committee of the board of directors of the company held the fourth meeting of the audit committee of the second board of directors, which deliberated and adopted the proposal on the financial statements of Cansino Biologics Inc(688185) Jinyu Bio-Technology Co.Ltd(600201) company for the first quarter of the three months ended March 31, 2021.
Cansino Biologics Inc(688185) Jinyu Bio-Technology Co.Ltd(600201) annual performance report of the audit committee of the board of directors of the company in 2021
On August 24, 2021, the audit committee of the board of directors of the company held the fifth meeting of the audit committee of the second board of directors, which deliberated and adopted the proposal on the interim financial statements of Cansino Biologics Inc(688185) Jinyu Bio-Technology Co.Ltd(600201) company for the six months ended June 30, 2021 and the audit report for the half year of 2021.
On October 26, 2021, the audit committee of the board of directors of the company held the sixth meeting of the audit committee of the second board of directors, which deliberated and adopted the proposal on the financial statements of Cansino Biologics Inc(688185) Jinyu Bio-Technology Co.Ltd(600201) company for the third quarter of the nine months ended September 30, 2021.
3、 Performance of the audit committee
1. Supervise and evaluate the work of external audit institutions
During the reporting period, the audit committee of the board of directors investigated and evaluated the audit work of the company’s domestic audit institution Deloitte Huayong Certified Public Accountants (special general partnership) and overseas audit institution Deloitte guanhuang Chenfang certified public accountants in 2021, and believed that the institution could carry out the audit work in strict accordance with the relevant national regulations and the professional norms of certified public accountants, Follow the principle of independence and give objective and fair audit opinions.
2. Guidance on internal audit of the company
In 2021, the audit committee of the board of directors of the company guided the company’s internal audit institutions to carry out their own work from a professional perspective, urged the company’s internal audit institutions to strictly implement the audit work plan, and put forward guiding suggestions for internal audit, which improved the effectiveness of internal audit.
3. Review and comment on the company’s financial report
In 2021, the audit committee of the board of directors reviewed the company’s financial report, widely communicated with the company’s management on the preparation and key issues of the financial report, and supervised the authenticity, accuracy and integrity of the company’s financial report from a professional perspective. The Audit Committee believes that the company’s financial report is true and accurate, and there are no major defects in the company’s internal control.
4. Guidance on the company’s internal control
In 2021, the audit committee of the board of directors of the company gave full play to the role of professional committees, actively promoted the construction of the company’s internal control system, urged the construction of the company’s internal control standard system, guided the Audit Department of the company to actively and steadily promote the construction of the company’s internal control standard system in combination with the actual situation of the company, so that the company’s internal control system can
Cansino Biologics Inc(688185) Jinyu Bio-Technology Co.Ltd(600201) annual performance report of the audit committee of the board of directors of the company in 2021
Effective implementation.
5. Coordinate the communication between management, internal audit department and relevant departments and external audit institutions
During the reporting period, in order to better enable the management and internal audit department to fully and effectively communicate with the domestic audit institution Deloitte Huayong Certified Public Accountants (special general partnership) and the overseas audit institution Deloitte guanhuang Chenfang certified public accountants, the audit committee of the board of directors of the company actively coordinated through multiple channels, fully listened to the opinions of all parties, improved the audit efficiency and jointly played the audit supervision function.
4、 Overall evaluation
The board of directors and the audit committee performed their duties in accordance with the provisions of the articles of association, the articles of association of the listed company, the articles of association of the listed company and the due diligence report of the Audit Committee during the listing period.
In 2022, in combination with the actual business development needs of the company, we will actively pay attention to the production and operation status, urge and guide the internal audit department of the company to continue to optimize the internal audit business, maintain full communication with external audit institutions, give advice and suggestions to the board of directors, and urge the compliance, stable and healthy operation of all businesses of the company.
Hereby report!
Cansino Biologics Inc(688185) Jinyu Bio-Technology Co.Ltd(600201) Audit Committee of the board of directors March 21, 2022
